Stay updated on Durvalumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference10%

- Check31 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0, indicating a new release with presumably added or fixed features.SummaryDifference0.2%

- Check46 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.6%

- Check53 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.6%

- Check60 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. This indicates a shift towards a more streamlined presentation of study status information.SummaryDifference35%

- Check74 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%

Stay in the know with updates to Durvalumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Lung Cancer Clinical Trial page.